We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$93.2M
AUM Growth
+$3.31M
Cap. Flow
+$475K
Cap. Flow %
0.51%
Top 10 Hldgs %
34.84%
Holding
132
New
12
Increased
21
Reduced
60
Closed
11

Top Sells

Rank Stock Value
1
AAOI icon
Applied Optoelectronics
AAOI
+$1.03M
2
SYF icon
Synchrony
SYF
+$822K
3
NEO icon
NeoGenomics
NEO
+$656K
4
SQNM
SEQUENOM INC NEW
SQNM
+$516K
5
AAPL icon
Apple
AAPL
+$457K

Sector Composition

Rank Sector Weight
1 Healthcare 55.95%
2 Industrials 11.04%
3 Technology 9.74%
4 Consumer Staples 3.77%
5 Consumer Discretionary 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$465B
$1.09M 1.17%
18,475
-100
-0.5% -$5.76K
SSP icon
27
E.W. Scripps
SSP
$270M
$1.08M 1.16%
56,800
-750
-1% -$15.3K
IDXX icon
28
Idexx Laboratories
IDXX
$44.9B
$1.02M 1.1%
14,000
JCP
29
DELISTED
J.C. Penney Company, Inc.
JCP
$1M 1.08%
150,400
-1,000
-0.7% -$8.34K
NSPH
30
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$943K 1.01%
+1,540,594
New +$2.12M
LIQT icon
31
LiqTech
LIQT
$20.5M
$905K 0.97%
28,063
-1,778
-6% -$64.6K
AFL icon
32
Aflac
AFL
$65.5B
$901K 0.97%
30,100
-200
-0.7% -$6.22K
LFVN icon
33
LifeVantage
LFVN
$80.1M
$890K 0.96%
93,482
-8,239
-8% -$62.2K
ABT icon
34
Abbott
ABT
$187B
$884K 0.95%
19,675
-3,450
-15% -$152K
CASC
35
DELISTED
Cascadian Therapeutics, Inc.
CASC
$847K 0.91%
63,558
-1,550
-2% -$26.7K
MSFT icon
36
Microsoft
MSFT
$2.9T
$840K 0.9%
15,135
+6,575
+77% +$346K
AEGN
37
DELISTED
Aegion Corp
AEGN
$827K 0.89%
+42,850
New +$850K
SWK icon
38
Stanley Black & Decker
SWK
$14.5B
$800K 0.86%
7,500
-50
-0.7% -$5.27K
APYX icon
39
Apyx Medical
APYX
$162M
$787K 0.84%
374,709
+80,750
+27% +$156K
PRTS icon
40
CarParts.com
PRTS
$42.6M
$779K 0.84%
26,415
-7,600
-22% -$180K
USPH icon
41
US Physical Therapy
USPH
$1.22B
$778K 0.83%
14,500
T icon
42
AT&T
T
$164B
$766K 0.82%
29,475
+5,164
+21% +$131K
JCI icon
43
Johnson Controls International
JCI
$85.1B
$763K 0.82%
18,455
-2,459
-12% -$111K
EXPD icon
44
Expeditors International
EXPD
$22.3B
$762K 0.82%
16,900
+750
+5% +$36.4K
SJM icon
45
J.M. Smucker
SJM
$13.5B
$734K 0.79%
5,950
STRR
46
DELISTED
Star Equity Holdings
STRR
$732K 0.79%
2,530
-260
-9% -$71.5K
ETRM
47
DELISTED
EnteroMedics Inc.
ETRM
$720K 0.77%
5,270
+1,710
+48% +$355K
KMB icon
48
Kimberly-Clark
KMB
$37.6B
$687K 0.74%
5,400
VCEL icon
49
Vericel Corp
VCEL
$2.38B
$669K 0.72%
259,250
-47,000
-15% -$105K
GSK icon
50
GSK
GSK
$107B
$636K 0.68%
12,600
+1,000
+9% +$51K

Similar funds

Perkins Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Perkins Capital Management held 132 positions worth $93.2M, up 3.7% from $89.9M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Perkins Capital Management's Q4 2015 filing shows 12 new, 21 increased, 60 reduced and 11 closed positions. Its largest new stake was NANOSPHERE INC. COM NEW: 1,540,594 shares worth $943K. The largest sale was Applied Optoelectronics, an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 53% a quarter earlier, followed by Industrials and Technology.

  • Perkins Capital Management's largest Q4 2015 buy was NANOSPHERE INC. COM NEW: 1,540,594 shares worth $943K.
  • Perkins Capital Management added most to EnteroMedics Inc. in Q4 2015, an estimated $355K increase.
  • Perkins Capital Management's biggest Q4 2015 reduction was NeoGenomics, cutting an estimated $656K.
  • Perkins Capital Management fully exited Applied Optoelectronics in Q4 2015, selling an estimated $1.03M.
  • Perkins Capital Management's ten largest holdings make up 35% of its $93.2M portfolio in Q4 2015.
  • Perkins Capital Management opened 12 new positions and closed 11 in Q4 2015.
  • Perkins Capital Management's portfolio value rose 3.7% quarter-over-quarter to $93.2M.

Based on Perkins Capital Management's 13F filing for Q4 2015, filed 28 Jan 2016.